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A B S T R A C T
A 75-year-old woman with a history of immunosuppressive treatment for rheumatoid arthritis and non-
Hodgkin lymphoma, was referred to our reference centre for treatment of tenosynovitis caused by
Mycobacterium malmoense, which had disseminated due to immunosuppressive therapy. This rare
diagnosis was made after years of treatment for supposed rheumatoid arthritis. The patient presented
with relapsing tenosynovitis with wounds on her right middle ﬁnger and wounds on her left lower leg,
despite 3 months of adequate therapy (rifampicin + ethambutol + clarithromycin). Therapy was
intensiﬁed with amikacin, clofazimine, moxiﬂoxacin, and interferon-gamma due to the lack of response.
Amputation of the right middle ﬁnger was necessary due to advanced disease. Treatment was further
complicated by a paradoxical reaction, requiring prednisone treatment, which ultimately led to cure.
© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Case report
A 75-year-old woman was referred to our reference centre for
non-tuberculous mycobacterial tenosynovitis of the right middle
ﬁnger 8 years after ﬁrst presentation. The patient had ﬁrst
presented with tenosynovitis of the right middle ﬁnger and
arthritis of the right wrist in 2008, which was presumed to be a
seronegative, non-erosive rheumatoid arthritis. Histological anal-
ysis of a biopsy specimen showed chronic inﬂammation, not
speciﬁc to rheumatoid arthritis. Bacterial cultures remained
negative at this time. The tenosynovitis was ﬁrst treated with
non-steroidal anti-inﬂammatory drugs and local corticosteroid
injections, with good effect. Later, arthritis of the right wrist and
tenosynovitis relapsed. As a result, the patient started treatment
with methotrexate.
One year later, the tenosynovitis deteriorated and exploratory
surgery was performed. Granulomatous inﬂammation was found
in pathology samples, but cultures remained negative. Over the
next 6 years, the disease slowly progressed and therapy with
etanercept, adalimumab, certolizumab, tocilizumab, abatacept,
and clarithromycin monotherapy proved unsuccessful. At this
point she was diagnosed with non-Hodgkin lymphoma, which was
treated with chemotherapy and radiotherapy. After this period,
due to a relapse of symptoms, localized corticosteroid injections,
gold injections, methotrexate, and prednisone were tried, and also
proved unsuccessful.
Eight years after initial presentation, a biopsy of synovium of
the wrist yielded growth of Mycobacterium malmoense and
antimycobacterial treatment with rifampicin, ethambutol, and
clarithromycin was initiated. At the start of antimycobacterial
therapy, the immunomodulatory treatment for rheumatoid
arthritis was halted.
At referral, the patient presented with an infection of the right
middle ﬁnger with an open wound and a swollen right wrist.
Despite 3 months of adequate antimycobacterial treatment, there
was no clinical improvement. She also had bursitis of the right
elbow, arthritis of the left wrist, and wounds on her left lower leg
with erythema and ﬂuctuating swelling, which had recently
emerged. Physical examination showed a slender woman (BMI
20.5 kg/m2), without fever or abnormalities on chest examination.
A chest X-ray showed no abnormalities. Magnetic resonance
imaging (MRI) of the left lower leg showed subcutaneous ﬂuid
collections, but no signs of osteomyelitis. Autoimmune serology
and HIV serology remained negative and radiographs of both hands
did not reveal erosions typical of rheumatoid arthritis. At
admission, the patient switched ethambutol to clofazimine due
to adverse events, i.e. visual impairment.
During admission a positron emission tomography-computed
tomography (PET-CT) was performed, which showed multiple sites
of inﬂammation in the right hand and lower arm, left hand and
lower left leg, right-sided olecranon bursitis, and a spinous process
of vertebra L5 (Figure 1). Puncture ﬂuid from the olecranon bursa
grew M. malmoense after 8 weeks of incubation on Lowenstein–
Jensen medium; the isolate proved susceptible to all antibiotics in
the treatment regimen. Mycobacterial blood cultures remained
negative. Due to the possible progression of disease, moxiﬂoxacin,
amikacin, and subcutaneous interferon-gamma were added to the
rifampicin + clofazimine + clarithromycin regimen. Relapse or new
haematological malignancy was ruled out by bone marrow biopsy.
Interferon-gamma was discontinued due to a severe ﬂu-like
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syndrome. Eventually, amputation of the right middle ﬁnger was
performed. Histology of the amputated ﬁnger showed granuloma-
tous inﬂammation with acid-fast rods in auramine stains.
A paradoxical reaction was considered as a possible explanation
for the lack of improvement. Prednisone (starting dose of 1 mg/kg,
follow by a slow tapered schedule) was given and led to rapid
marked improvement of the patient’s clinical signs and symptoms.
After almost 4 months, prednisone could be stopped, as follow-up
PET-CT imaging conﬁrmed the decrease in severity of inﬂamma-
tion.
Due to adverse events, consisting of cutaneous reactions,
antimycobacterial drugs were halted after 9 months. As immuno-
modulatory treatment had been halted and the paradoxical
reaction had waned, it was estimated that the treatment had
been of a sufﬁcient duration. One year after cessation of antibiotics,
the patient has not had a recurrence of M. malmoense disease.
Discussion
This patient was suffering from relapsing tenosynovitis for
years. This was at ﬁrst attributed to rheumatoid arthritis, although
different treatments did not have the desired effect. Eventually, the
diagnosis of disseminated M. malmoense infection was made.
Based on the lack of response to all of the different treatments
given for rheumatoid arthritis, it is hypothesized that M.
malmoense tenosynovitis was the most likely diagnosis from the
beginning and that the patient probably had not suffered from
rheumatoid arthritis. Yet, with the many injections and wounds
present over time, M. malmoense may also have been inoculated
later in the course of disease.
Due to the immunomodulatory medication use, the mycobac-
terial disease had the opportunity to disseminate. After interrupt-
ing the immunosuppressive drugs and starting the
antimycobacterial drugs, the immune system recovered and
different lesions at sites to which M. malmoense had spread
became apparent. This was ﬁrst interpreted as a poor clinical
response, but eventually as a paradoxical reaction. As a result,
prednisone was started, which had a good effect. Although
paradoxical reactions are well described in the treatment of
tuberculosis (Melboucy-Belkhir et al., 2010), almost no case
reports on non-tuberculous mycobacteria (NTM) are available.
Theoretically, a similar paradoxical response as seen in tuberculo-
sis could be expected in the treatment of NTM as well. In this case,
the cessation of anti-inﬂammatory drugs used for rheumatoid
arthritis might have contributed to the paradoxical response.
As a differential diagnosis, Poncet’s disease was also considered.
Poncet’s disease was ﬁrst described in tuberculosis patients in
1897. It is a rare presentation of reactive polyarthritis, without
mycobacterial involvement of the joint. After infection, as a result
of systemic immunization, sensitized CD4+ cells together with
bacterial antigens migrate to the joints and cause arthritis (Sharma
et al., 2016). In the case presented herein, the positive cultures
eventually ruled out Poncet’s disease.
The incidence of M. malmoense infections has increased since
1980, especially in northern Europe (Hoefsloot et al., 2008).
Pulmonary infections are the most frequent disease manifestation
(Hoefsloot et al., 2009). Extrapulmonary M. malmoense infection is
rare, except for lymphadenitis in children and tenosynovitis
(Hoefsloot et al., 2008). Dissemination is only observed in patients
with severely impaired immunity (Zaugg et al., 1993). In this case,
Figure 1. PET-CT Lesions are visible in the right hand and lower arm, matching infection. Lesions in the left hand and left lower leg, as well as two spots in the intestines and
possibly the spinous process of L5, are consistent with infection. Pictures of the right hand, right elbow and left lower leg are provided as well.
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the patient had multiple causes of impaired immunity, not only
due to immunosuppressive medication, but also due to for instance
non-Hodgkin lymphoma.
The diagnosis of M. malmoense disease was further complicated
by the fact that M. malmoense is a slow-growing Mycobacterium
that can take up to 8 weeks to grow in mycobacterial culture.
Supplementing the medium with pyruvate and acidiﬁcation of the
medium to a pH of 6 can help to increase the growth rate of
M. malmoense and ensure its detection (Katila et al., 1989). Direct
detection of NTM in clinical samples by molecular techniques can
further increase the sensitivity of mycobacterial diagnostics
(Deggim-Messmer et al., 2016).
In conclusion, immunosuppressive medication can cause
dissemination of otherwise localized infections with M. mal-
moense. The diagnosis and treatment of M. malmoense tenosyno-
vitis can be challenging. Paradoxical reactions should be
considered in the case of treatment failure.
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